Foghorn Therapeutics, Inc. (FHTX)
6.00
-0.22
(-3.54%)
USD |
NASDAQ |
Aug 28, 16:00
6.00
0.00 (0.00%)
After-Hours: 18:38
Foghorn Therapeutics Total Assets (Quarterly) : 203.39M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 203.39M |
| March 31, 2026 | 222.17M |
| December 31, 2025 | 394.66M |
| September 30, 2025 | 204.96M |
| June 30, 2025 | 226.24M |
| March 31, 2025 | 258.69M |
| December 31, 2024 | 458.37M |
| September 30, 2024 | 308.37M |
| June 30, 2024 | 328.58M |
| March 31, 2024 | 255.00M |
| December 31, 2023 | 285.92M |
| September 30, 2023 | 313.42M |
| Date | Value |
|---|---|
| June 30, 2023 | 339.58M |
| March 31, 2023 | 372.88M |
| December 31, 2022 | 404.88M |
| September 30, 2022 | 433.93M |
| June 30, 2022 | 456.90M |
| March 31, 2022 | 488.30M |
| December 31, 2021 | 519.77M |
| September 30, 2021 | 186.07M |
| June 30, 2021 | 208.53M |
| March 31, 2021 | 229.89M |
| December 31, 2020 | 255.59M |
| September 30, 2020 | 142.43M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Prime Medicine, Inc. | 249.04M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 284.43M |
| Shareholders Equity (Quarterly) | -81.04M |
| Debt to Equity Ratio | -0.5319 |
| Current Ratio | 3.362 |
| Net Debt Paydown Yield | -0.58% |